Hepatic expression of PPARα, a molecular target of fibrates, is regulated during inflammation in a gender-specific manner

FEBS Letters

Volumn 546, Issue 2-3, 2003, Pages 237-240

  Tai, E Shyong ^a   Bin Ali, Azhar ^b   Zhang, Qian ^b   Loh, Lih Ming ^a   Tan, Chee Eng ^a   Retnam, Leslie ^b   El Oakley, Reida Menshawe ^b   Lim, Sai Kiang ^b,c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Cardiovascular disease; Gender; Inflammation; mRNA; Peroxisome proliferator activated receptor

Indexed keywords

CELL NUCLEUS RECEPTOR; FIBRIC ACID DERIVATIVE; LIPID; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; ANTILIPEMIC AGENT; CELL RECEPTOR; PRIMER DNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GONADECTOMY; INFLAMMATION; LIPID METABOLISM; LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA ANALYSIS; SEX DIFFERENCE; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY;

ANIMALS; ANTILIPEMIC AGENTS; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SEX FACTORS; TRANSCRIPTION FACTORS;

EID: 0037523216     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00578-7     Document Type: Article

References (22)

1. Barbier O., Torra I.P., Duguay Y., Blanquart C., Fruchart J.-C., Glineur C., Staels B. Arterioscler. Thromb. Vasc. Biol. 22:2002;717-726.
2. Francis G.A., Annicotte J.S., Auwerx J. Am. J. Physiol. Heart Circ. Physiol. 6:2003;6.
3. Desvergne B., Wahli W. Endocr. Rev. 20:1999;649-688.
4. Chinetti G., Fruchart J.C., Staels B. Z. Kardiol. 90:2001;125-132.
5. Chinetti G., Fruchart J.C., Staels B. Inflamm. Res. 49:2000;497-505.
6. Daynes R.A., Jones D.C. Nat. Rev. Immunol. 2:2002;748-759.
7. Delerive P., Fruchart J.C., Staels B. J. Endocrinol. 169:2001;453-459.
8. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., Wahli W. Nature. 384:1996;39-43.
9. Clark R.B. J. Leukoc. Biol. 71:2002;388-400.
10. Ginsberg H.N., Stalenhoef A.F. J. Cardiovasc. Risk. 10:2003;121-128.
11. Ansell B. Adv. Ther. 19:2002;61-72.
12. Gotto A.M. Jr. Am. J. Med. 112:2002;10S-18S.
13. Ross, R. and Fuster, V. (1996) In: Atherosclerosis and Coronary Disease, Vol. 2 (Fuster, V., Ross, R. and Topol, E.J., Eds.), pp. 441-460, Lippincott-Raven Publishers, Philadelphia.
14. Lemberger T., Saladin R., Vazquez M., Assimacopoulos F., Staels B., Desvergne B., Wahli W., Auwerx J. J. Biol. Chem. 271:1996;1764-1769.
15. bin Ali A., Zhang Q., Lim Y.K., Fang D., Retnam L., Lim S.K. Free Radic. Biol. Med. 34:2003;824-829.
16. Lim Y.K., Retnam L., Bhagavath B., Sethi S.K., bin Ali A., Lim S.K. Atherosclerosis. 160:2002;311-316.
17. Lim S., Mullins J.J., Chen C.M., Gross K.W., Maquat L.E. EMBO J. 8:1989;2613-2619.
18. Lim Y.K., et al. Kidney Int. 58:2000;1033-1044.
19. Steineger H.H., Sorensen H.N., Tugwood J.D., Skrede S., Spydevold O., Gautvik K.M. Eur. J. Biochem. 225:1994;967-974.
20. Lemberger T., Staels B., Saladin R., Desvergne B., Auwerx J., Wahli W. J. Biol. Chem. 269:1994;24527-24530.
21. Frederic F., Oliver C., Wollman E., Delhaye-Bouchaud N., Mariani J. Eur. Cytokine Netw. 4:1993;321-329.
22. Da Silva J.A.P. Ann. N.Y. Acad. Sci. 876:1999;102-118.